High Risk Features Contrast With Favorable Outcomes in HIV-associated Hodgkin Lymphoma in the Modern cART Era, ANRS CO16 LYMPHOVIR Cohort.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Clinical Infectious Diseases

• Publication date

  2015-07-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/cid/civ627PMID 26223997
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hodgkin lymphoma is as common as non‐Hodgkin lymphoma in HIV‐positive patients with sustained viral suppression and limited immune deficiency: a prospective cohort study

  2015cited by this paper
• How I treat classical Hodgkin lymphoma in patients infected with human immunodeficiency virus.

  2015cited by this paper
• Prognostic factors for advanced‐stage human immunodeficiency virus‐associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: A multi‐institutional retrospective study

  2015cited by this paper
• Risk assessment in the management of newly diagnosed classical Hodgkin lymphoma.

  2015cited by this paper
• Diagnosis and management of lymphomas and other cancers in HIV-infected patients

  2014cited by this paper
• Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009: results from a French cohort

  2014cited by this paper
• Prevalence of HIV Infection among U.S. Hodgkin Lymphoma Cases

  2013cited by this paper
• Risk of AIDS-defining cancers among HIV-1-infected patients in France between 1992 and 2009: results from the FHDH-ANRS CO4 cohort.

  2013cited by this paper
• Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era.

  2013cited by this paper
• Effect of Immune Reconstitution on the Incidence of HIV-Related Hodgkin Lymphoma

  2013cited by this paper
• HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era.

  2012cited by this paper
• Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics.

  2012cited by this paper
• How I treat HIV-associated lymphoma.

  2012cited by this paper
• Stage-adapted treatment of HIV-associated Hodgkin lymphoma: results of a prospective multicenter study.

  2012cited by this paper
• Ten‐year survival among HIV‐1‐infected subjects with AIDS or non‐AIDS‐defining malignancies

  2012cited by this paper
• The spectrum of malignancies in HIV‐infected patients in 2006 in France: The ONCOVIH study

  2011cited by this paper
• Cancer burden in the HIV-infected population in the United States.

  2011cited by this paper
• HIV-associated Hodgkin lymphoma during the first months on combination antiretroviral therapy.

  2011cited by this paper
• Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study

  2010cited by this paper
• Circulating serum free light chains as predictive markers of AIDS-related lymphoma.

  2010cited by this paper
• HIV-associated lymphomas and gamma-herpesviruses.

  2009cited by this paper
• Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study.

  2009cited by this paper
• A Meta-Analysis of the Incidence of Non-AIDS Cancers in HIV-Infected Individuals

  2009cited by this paper
• A mouse model of allogeneic corneal endothelial cell transplantation.

  2008cited by this paper
• Characteristics and Outcome of AIDS-Related Hodgkin Lymphoma Before and After the Introduction of Highly Active Antiretroviral Therapy

  2008cited by this paper
• Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's lymphoma.

  2007cited by this paper
• Revised response criteria for malignant lymphoma.

  2007cited by this paper
• Bulky disease is the most important prognostic factor in Hodgkin lymphoma stage IIB

  2003cited by this paper
• Improved survival in HIV-related Hodgkin's lymphoma since the introduction of highly active antiretroviral therapy

  2003cited by this paper
• Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy.

  2001cited by this paper
• A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease.

  1998cited by this paper
• Lymphomas associated with HIV infection.

  1997cited by this paper

• Recognizing Lymphoma Risk in EBV- and HIV-Positive Patients: The Otorhinolaryngologist’s Perspective

  2026cites this paper
• Estimates of global, regional, and national incidence of Hodgkin lymphoma attributable to Human Immunodeficiency virus: A population attributable modeling study

  2025cites this paper
• Chimeric antigen receptor T-cell therapy and bispecific antibodies in the treatment of lymphoma for human immunodeficiency virus-infected patients: A systematic review

  2025cites this paper
• Early-stage Hodgkin lymphoma in Cape Town, South Africa: prognostic risk factors at diagnosis and treatment outcomes

  2025cites this paper
• THE FIRST SUCCESSFUL EXPERIENCE OF HIGH-DOSE CHEMOTHERAPY FOLLOWING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HODGKIN LYMPHOMA IN A PATIENT WITH HIV INFECTION AT THE PIROGOV NATIONAL MEDICAL AND SURGICAL CENTER

  2024cites this paper
• Real-world treatment outcomes for Hodgkin lymphoma in South Africa: a prospective observational study

  2024cites this paper
• A comparison of clinical profile and treatment outcome of Hodgkin’s Lymphoma in Tanzania according to HIV status during the HAART era

  2024cites this paper
• Stage‐adapted treatment of HIV‐associated Hodgkin lymphoma: Long‐term results of a prospective, multicenter study

  2024cites this paper
• Clinical features in Hodgkin lymphoma patients living with human immunodeficiency virus: A meta-analysis in the antiretroviral therapy era

  2024cites this paper
• Pathogenetic parallels and clinical relationships of HIV infection and Hodgkin’s lymphoma

  2024cites this paper
• Safety, efficacy, and affordability of ABVD for Hodgkin lymphoma in Malawi: a prospective cohort study

  2024cites this paper
• Experience in the treatment of Hodgkin’s lymphoma associated with HIV

  2023cites this paper
• CD4+ T cell count in HIV/TB co-infection and co-occurrence with HL: Case report and literature review

  2023cites this paper
• Brentuximab vedotin with AVD for stage II-IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial.

  2023cites this paper
• The International Prognostic Score and HIV status predict red cell concentrate transfusion needs in Hodgkin lymphoma

  2022cites this paper
• Epidemiology and results of the first line therapy for HIV-related Hodgkin lymphoma

  2022cites this paper
• A Rare Case of Good Outcome of Hodgkin Lymphoma in a Patient with HIV on Antiretroviral Therapy (ART)

  2022cites this paper
• First Extensive Analysis of 18F-Labeled Fluorodeoxyglucose Positron Emission Tomography–Computed Tomography in a Large Cohort of Patients With HIV-Associated Hodgkin Lymphoma: Baseline Total Metabolic Tumor Volume Affects Prognosis

  2022cites this paper
• Progress in the Treatment of HIV-Associated Lymphoma When Combined With the Antiretroviral Therapies

  2022cites this paper
• Overall survival in Chilean patients with lymphoma and human immunodeficiency virus: A retrospective cohort study

  2021cites this paper
• Hematological cancers in individuals infected by HIV.

  2021cites this paper
• Increased Production of B-Cell Activating Cytokines and Altered Peripheral B-Cell Subset Distribution during HIV-Related Classical Hodgkin Lymphoma

  2021cites this paper
• Estimating the global burden of Epstein–Barr virus-related cancers

  2021cites this paper
• What to Do for Increasing Cancer Burden on the African Continent? Accelerating Public Health Diagnostics Innovation for Prevention and Early Intervention on Cancers

  2021cites this paper
• HIV-associated lymphoma—advances in clinical management

  2021cites this paper
• Hodgkin Lymphoma in People Living with HIV

  2021influential citation
• [Human immunodeficiency virus and lymphoma].

  2021cites this paper
• Prospective evaluation of blood Epstein–Barr virus DNA load and antibody profile in HIV-related non-Hodgkin lymphomas

  2021cites this paper
• The Management of HIV-Hodgkin Lymphoma

  2020cites this paper
• Risk, Diagnostic and Predictor Factors for Classical Hodgkin Lymphoma in HIV-1-Infected Individuals: Role of Plasma Exosome-Derived miR-20a and miR-21

  2020cites this paper
• HIV Lymphoma and Burkitts Lymphoma

  2020cites this paper
• Sintilimab as salvage treatment in an HIV patient with relapsed/ refractory Hodgkin: a case report.

  2020cites this paper
• Epidemiology of haematological malignancies in people living with HIV.

  2020cites this paper
• Favorable outcome of HIV-associated Burkitt lymphoma in the modern combined antiretroviral therapy era.

  2020cites this paper
• Optimizing treatment for HIV-associated lymphoma.

  2019cites this paper
• Epstein-Barr virus biomarkers have no prognostic value in HIV-related Hodgkin lymphoma in the modern cART era.

  2019cites this paper
• HCV or HBV coinfection and lymphoma risk in people living with HIV.

  2019cites this paper
• Hiv and Lymphoma: from Epidemiology to Clinical Management

  2019cites this paper
• Hodgkin lymphoma in the modern combined antiretroviral therapy era

  2019influential citation
• [Isolated digestive localization of Hodgkin lymphoma in an HIV-infected patient, detected after hemophagocytic lymphohistiocytosis].

  2019cites this paper
• Malignant lymphoma in the HIV‐positive patient

  2018cites this paper
• Diagnosis and Treatment of Hodgkin Lymphoma

  2018cites this paper
• Hodgkin lymphoma at Groote Schuur Hospital, South Africa: the effect of HIV and bone marrow infiltration

  2018cites this paper
• Prognostic Value of Pre-treatment F-18 FDG PET Metabolic Metrics in Patients with Locally Advanced Carcinoma of the Anus with and without HIV Infection

  2018cites this paper
• Utility of Epstein-Barr Virus Biomarkers in Human Immunodeficiency Virus-related Lymphomas in the Modern Combined Antiretroviral Therapy Era.

  2018cites this paper
• Reply to Lupo et al.

  2018influential citation
• 18F-FDG-PET metabolic metrics and International Prognostic Score for risk assessment in HIV-infected patients with Hodgkin lymphoma

  2018cites this paper
• Cancer in People Living With HIV, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology.

  2018cites this paper
• Lymphomes associés à l’infection par le virus de l’immunodéficience humaine

  2018cites this paper
• HIV-Associated Malignant Lymphoma

  2017cites this paper
• HIV-infection has no prognostic impact on advanced-stage classical Hodgkin lymphoma.

  2017cites this paper
• Feasibility of interim positron emission tomography (PET)-adapted therapy in HIV-positive patients with advanced Hodgkin lymphoma (HL): a sub-analysis of SWOG S0816 Phase 2 trial

  2017cites this paper
• Survival and predictors of death in people with HIV-associated lymphoma compared to those with a diagnosis of lymphoma in general population

  2017cites this paper
• The role of F-18 FDG PET/CT in evaluating the impact of HIV infection on tumor burden and therapy outcome in patients with Hodgkin lymphoma

  2017cites this paper
• Brentuximab vedotin with AVD shows safety, in the absence of strong CYP3A4 inhibitors, in newly diagnosed HIV-associated Hodgkin lymphoma

  2017influential citation
• Syndrome mononucléosique et pathologies hématologiques liées au virus d’Epstein-Barr

  2017cites this paper
• Non-AIDS-related malignancies: expert consensus review and practical applications from the multidisciplinary CANCERVIH Working Group.

  2016cites this paper
• Outcomes of HIV-associated Hodgkin lymphoma in the era of antiretroviral therapy

  2016cites this paper
• EPSTEIN-BARR VIRUS VIRAL LOAD IN HIV-ASSOCIATED LYMPHOMAS

  2016cites this paper
• HIV-assoziierte Lymphome

  2008cites this paper